로딩 중…
지수 로딩 중…
Aldeyra Therapeutics, Inc.
ALDX· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$1.53-0.65%
2026-08-03
Financials
Valuation Metrics
Aldeyra Therapeutics, Inc.'s Market Cap is $92M. At end of 2025 it was $312M. Ranked #3082 of 3,112 in US market (top 99%), #1417 of 1,445 on NASDAQ (top 98%), #267 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 99%) by Market Cap.
Investment Metrics(as of 2026-08-03)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $92M | US#3,082/3,112 Sec#267/269 |
| Revenue | $0.00 | US#2,974/3,112 Sec#204/269 |
| Net Income | $-27M | US—/3,112 Sec—/269 |
| Total Assets | $66M | US#3,049/3,112 Sec#269/269 |
| Net Assets | $42M | US#2,948/3,112 Sec#244/269 |
| Value | ||
| P/B | 2.19x | US#1,298/3,112 Sec#58/269 |
| FCF Yield | -28.16% | US—/3,112 Sec—/269 |
| Profitability | ||
| ROE | -64.92% | US#2,790/3,112 Sec#196/269 |
| ROA | -41.17% | US#2,930/3,112 Sec#195/269 |
| Financial Health | ||
| Debt Ratio | 57.70% | US#647/3,112 Sec#147/269 |
| Total Debt | $16M | US#2,735/3,112 Sec#189/269 |
| FCF | $-26M | US#2,391/3,112 Sec#97/269 |
| Cash | $65M | US#2,460/3,112 Sec#207/269 |
| Current Ratio | 2.72x | US#902/3,112 Sec#202/269 |
| Performance | ||
| 1Y Return | -68.19% | US#3,089/3,112 Sec#264/269 |
| 1M Return | -32.60% | US#3,078/3,112 Sec#259/269 |
| From 52W High | -75.24% | US#3,062/3,112 Sec#262/269 |
| 1Y MDD | -78.95% | US#3,039/3,112 Sec#259/269 |
| Trading | ||
| Volume | 781,912 shares | US#1,705/3,112 Sec#163/269 |
| Trading Value | $1M | US#3,005/3,112 Sec#253/269 |
| Per Share | ||
| EPS | $-0.56 | US—/3,112 Sec—/269 |
| BPS | $735511.14 | US#3/3,112 Sec#2/269 |